IN THE NEWS
Dr Debbie Palmer discusses the importance of allergy research
In the news
To give you the best experience, this site uses cookies. Learn more about cookies
The ultimate goal of The ORIGINS Project is to reduce the rising epidemic of non-communicable diseases through 'a healthy start to life'.
As well as ORIGINS long-term core research, there are a number of clinical trials, early interventions and shorter-term research studies that sit within the project.
The ORIGINS Project provides researchers, students, clinicians and universities with a unique opportunity to play a crucial role in changing the health of future generations.
By age one, 10% of babies will develop a food allergy, with egg and peanut the most common allergic foods.
We have recently discovered that regular inclusion of egg and peanut in solid foods can reduce food allergies, however this is too late for some babies.
We are now trying to answer the question of whether the amount of eggs and peanuts a mother eats during pregnancy and breastfeeding has an influence on reducing the chances her baby will develop an egg or peanut food allergy.
Women who are less than 23 weeks gestation can enroll into the PrEggNut Study to be involved during pregnancy and while breastfeeding. We are aiming to recruit between 200 and 300 PrEggNut Study participants.
We are looking for families with two or more family members (mother, father, brother or sister of the new expected baby) who have had either eczema, asthma, hay fever and/or a food allergy.
Recruitment for the BENEFIT study is now closed. Women between 23-36 weeks gestation were invited to enroll in the BENEFIT Study and are involved from birth while breastfeeding.
Both studies involve the mother being allocated to a diet containing different amounts of eggs and peanuts. Participants receive complementary peanuts and peanut butter, breastfeeding advice if needed, and dietary education on the introduction of solid foods to their baby.